Boehringer Ingelheim: all 2,305 studies
Page 18 of 24. Open to participants first (62), then studies with results posted, then the rest; newest registration first within each.
- Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male SubjectsCompletedNCT02218684Phase 1
- Pharmacological Study on Absorption of WE 941 OD Tablets in Japanese Healthy Male VolunteersCompletedNCT02218671Phase 1
- Bioequivalence Between WE 941 OD and Brotizolam (Lendormin®) in Healthy Adult MalesCompletedNCT02218658Phase 1
- Bioequivalence Between WE 941 OD and Brotizolam (Lendormin®) Taken With Water in Healthy Adult MalesCompletedNCT02218645Phase 1
- Safety, Tolerability and Pharmacokinetics of BI 653048 H3PO4 Oral Drinking Solution in Healthy Male VolunteersCompletedNCT02217644Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 653048 BS H3PO4 Capsule Multiple Rising Doses in Healthy Male VolunteersCompletedNCT02217631Phase 1
- Effects of BI 44370 TA Orally Applied as Tablets on the Pharmacokinetics of Orally Administered Midazolam Solution in Healthy VolunteersCompletedNCT02217514Phase 1
- Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS for HandiHaler® in Healthy Male VolunteersCompletedNCT02216461Phase 1
- Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb IschaemiaTerminatedNCT02215824Phase 1
- Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino PatientsCompletedNCT02215798
- Metabolism and Pharmacokinetics of [14C]-BI 44370 BS Administered as an Oral Solution in Healthy Male VolunteersCompletedNCT02215772Phase 1
- Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 44370 TA Tablets in Healthy Male and Female VolunteersCompletedNCT02215759Phase 1
- Bioavailability of BI 44370 TA Drinking Solution or Tablets With and Without a High Fat Meal in Healthy Male and Female VolunteersCompletedNCT02215746Phase 1
- The Use of Angiotensin Receptor Blockers and the Risk of CancerCompletedNCT02215733
- Dose-finding Study of BI 2536 Administered in Combination With Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic CancerTerminatedNCT02215044Phase 1
- Safety, Tolerability and Pharmacokinetics of Single Rising Intravenous Doses of BI 44370 BS Solution in Healthy Male VolunteersCompletedNCT02215031Phase 1
- Safety, Tolerability and Pharmacokinetics of BI 44370 TA Oral Drinking Solution in Healthy Male VolunteersCompletedNCT02215018Phase 1
- Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female VolunteersCompletedNCT02215005Phase 1
- Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female VolunteersCompletedNCT02214992Phase 1
- Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female VolunteersCompletedNCT02214979Phase 1
- Influence of Food on the Bioavailability of Telmisartan / Ramipril Fixed Dose Combination in Healthy Male and Female VolunteersCompletedNCT02214966Phase 1
- Bioavailability of Four Oral Prototype Extended Release Formulations With BI 11634 in Healthy Male VolunteersCompletedNCT02214953Phase 1
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple, Rising Oral Doses of BI 11634 Oral Solution in Healthy Male VolunteersCompletedNCT02214940Phase 1
- Pharmacokinetics and Relative Bioavailability of 11634 Immediate Release Tablet in Healthy Male VolunteersCompletedNCT02214927Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 11634 Solution in Healthy Male VolunteersCompletedNCT02214914Phase 1
- Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS in Healthy Male VolunteersCompletedNCT02214901Phase 1
- Efficacy, Safety and Pharmacokinetics of BIRB 796 BS Tablets in Patients With Active Rheumatoid ArthritisTerminatedNCT02214888Phase 2
- Influence of a Standardised High Fat Breakfast on the Bioavailability of BI 14332 CL in Healthy Male VolunteersCompletedNCT02212938Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 DiabetesTerminatedNCT02212925Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 14332 CL Powder in Healthy Male SubjectsCompletedNCT02211989Phase 1
- Efficacy and Tolerability of Bisacodyl Sugar Coated Tablets, Simeticone Chewing Tablets and Their Combination in Constipation and BloatednessCompletedNCT02211976Phase 3
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 44847 in Female and Male Patients With Type 2 DiabetesCompletedNCT02211963Phase 1
- Relative Bioavailability of BI 44847 in Different Ethnic Groups and Evaluation of Effect of Diet and Acarbose Coadministration on Bioavailability Following Oral Administration of 200 mg BI 44847 in Healthy Male VolunteersCompletedNCT02211950Phase 1
- Relative Oral Bioavailability of BI 44847 as Suspension Compared to Tablet and the Influence of Food Anf of BI 44847 as Solution Compared to Tablet in Healthy Male VolunteersCompletedNCT02211937Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 44847 Administered to Healthy Male SubjectsCompletedNCT02211924Phase 1
- Pharmacokinetics of Bisacodyl or Sodium Picosulfate Administered Orally in Healthy Lactating FemalesCompletedNCT02211911Phase 1
- Clinical Study of BNS003 on Swelling in Legs Due to Venous RefluxCompletedNCT02211898Phase 3
- Excretion Balance of 14c-radiolabeled BIRB 796 BS in Normal Male SubjectsCompletedNCT02211885Phase 1
- BI 2536 BS in Patients With Advanced Solid Tumours and Repeated Administration in Patients With Clinical BenefitCompletedNCT02211872Phase 1
- Dose Escalation Study of BI 2536 BS in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical BenefitCompletedNCT02211859Phase 1
- Dose Escalation Study of BI 2536 With Pemetrexed in Previously Treated Patients With Non-small-cell Lung CancerCompletedNCT02211833Phase 1
- Effect of Single Oral Dose BIRB 796 BS on Endotoxin-induced Inflammatory Responses in Healthy Human SubjectsCompletedNCT02211170Phase 1
- Safety, Pharmacokinetics and Pharmacodynamics of BIRB 796 BS Tablets Administered to Healthy Human SubjectsCompletedNCT02211157Phase 1
- Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered Twice Daily Orally to Healthy Human SubjectsCompletedNCT02211144Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 44847 Powder in Healthy Male SubjectsCompletedNCT02209844Phase 1
- Bioavailability of Oral BIRB 796 BS Tablets With and Without Administration of Oral Pantoprazole in Healthy Male VolunteersCompletedNCT02209831Phase 1
- Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered to Healthy Human SubjectsCompletedNCT02209805Phase 1
- Dose Finding Study of BIRB 796 BS in Patients With Moderate to Severe Crohn's DiseaseTerminatedNCT02209792Phase 2
- Efficacy and Safety of Different Doses of BIRB 796 BS in Patients With Active Rheumatoid ArthritisCompletedNCT02209779Phase 2
- BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type PsoriasisCompletedNCT02209753Phase 2
- Single Dose Escalation Study of 131I-Sibrotuzumab in Patients With Advanced or Metastatic Non-small Cell Lung CancerTerminatedNCT02209727Phase 1
- Safety, Tolerability and Pharmacodynamics After Oral Administration of BIIF 1149 BS in Healthy Male VolunteersCompletedNCT02209714Phase 1
- Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid TumorsTerminatedNCT02209701Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ESR 1150 CL in Healthy SubjectsTerminatedNCT02209688Phase 1
- Bioavailability of Lacidipine and Telmisartan Fixed Dose Combination Tablets Relative to Separate Tablets in Healthy SubjectsCompletedNCT02209649Phase 1
- Safety, Pharmacokinetics and Pharmacodynamics of Single Rising Doses Oral BIRB 796 BS in Healthy Human SubjectsCompletedNCT02208856Phase 1
- Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential HypertensionCompletedNCT02206659Phase 3
- Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse® in Korean Patients With Acute Myocardial InfarctionCompletedNCT02206646
- Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Non-small Cell Lung CancerCompletedNCT02204059Phase 1
- Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Adenocarcinoma of the BreastCompletedNCT02204046Phase 1
- Dose Escalation Study With 99mTC - or 186 Re-labelled Humanised Monoclonal Antibody (hMAb) BIWA 4 in Patients With Head and Neck CancerCompletedNCT02204033Phase 1
- Dose Escalation Study to Evaluate Safety and Tolerability of an Allogeneic Tumor Vaccine BIWB 2 in Patients With Advanced Malignant MelanomaCompletedNCT02203864Phase 1
- Tolerability and Pharmacokinetics of Lacidipine With and Without the Co-administration of Telmisartan in Female and Male Healthy SubjectsCompletedNCT02203500Phase 1
- Safety, Tolerability and Pharmacokinetics of Increasing Repeated Doses of BIIF 1149 BS in Healthy Male VolunteersCompletedNCT02203487Phase 1
- Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial HypertensionCompletedNCT02202525
- Effect of Repeated Doses of BI 1060469 and BI 1021958 on Glomerular Filtration Rate (GFR) in Healthy VolunteersCompletedNCT02202512Phase 1
- A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT02200653Phase 4
- A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT02200640Phase 4
- Pharmacovigilance and Patient Compliance in Hypertensive PatientsCompletedNCT02200575
- Micardis®. Observational Study in Patients With Essential HypertensionCompletedNCT02200094
- Safety, Tolerability and Pharmacodynamics of BIIF 1149 BS in Healthy Young Male VolunteersCompletedNCT02199899Phase 1
- Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical ResectionTerminatedNCT02199886Phase 1
- Safety, Tolerability and Pharmacodynamics of BIIX 1 XX in Healthy Young Male VolunteersCompletedNCT02199873Phase 1
- Single Rising Dose Study Investigating the Safety, Tolerability and Pharmacokinetics of Spray Dried BIBN 4096 BS After Inhalation Administration in Healthy Male and Female VolunteersCompletedNCT02199860Phase 1
- Evaluation of the Effects of Pharmaton Tablets on Mental Performance and Physical Fatigue in Nurses Working Night ShiftCompletedNCT02199847Phase 2
- Study to Determine Tolerability After Intravenous Administration of BIBN 4096 BS in Healthy Male and Female VolunteersCompletedNCT02198352Phase 1
- Efficacy, Safety, Tolerability and Pharmacokinetics of BIBN 4096 BS Versus Placebo in the Treatment of a Single Attack of Acute Migraine HeadacheCompletedNCT02198339Phase 2
- Single Rising Dose Tolerability Study of BIBN 4096 BS in Healthy Male and Female VolunteersCompletedNCT02198326Phase 1
- A Multiple Increasing Dose Safety and Tolerability Study After Inhalation Administration of BIIX 1 XX in Healthy Male VolunteersTerminatedNCT02198313Phase 1
- Dose Extension Study of BIIX 1 XX in Healthy Young Male VolunteersCompletedNCT02198287Phase 1
- Intravenous BIBH 1 in Patients With Metastatic Colorectal CancerCompletedNCT02198274Phase 2
- Effectiveness and Safety of Synvisc® Versus Usual Treatments in Patients With Knee OsteoarthritisCompletedNCT02197026Phase 4
- A Prescription-Event Monitoring (PEM) Study of TiotropiumCompletedNCT02196194
- Bioavailability Study of Ranitidine Hydrochloride (Maximum Strength ZANTAC 150®) Compared to Two Different 150 mg Ranitidine Hydrochloride Oral Disintegrating Tablet (ODT) in Fasting, Healthy Male VolunteersCompletedNCT02195804Phase 1
- Retrospective Follow-up Study of Synvisc® in Patients With Knee OsteoarthritisCompletedNCT02195557
- Use of Synvisc® in Knee Osteoarthritis - Survey on PracticeCompletedNCT02195544
- Use of Synvisc® in Knee Osteoarthritis - Medico-economical StudyCompletedNCT02195505
- Retrospective Follow-up of Synvisc® in Active Patients With Knee OsteoarthritisCompletedNCT02195492
- Effects of Single-dose and Steady-state TPV/RTV on the Steady-state Pharmacokinetics of Fluconazole in Healthy Adult VolunteersCompletedNCT02195466Phase 1
- Safety, Tolerability and Pharmacokinetics of Inhalative Administration of BIBN 4096 BS in Healthy Male and Female VolunteersCompletedNCT02194777Phase 1
- Efficacy of a Standardised Bilberry Extract in Improving the Night Vision of Healthy VolunteersCompletedNCT02194361Phase 2
- Study to Determine Tolerability of Single Increasing Dose of BIBN 4096 BS in Healthy Male and Female VolunteersCompletedNCT02194348Phase 1
- Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIBN 4096 BS in Healthy Male and Female VolunteersCompletedNCT02194335Phase 1
- Safety, Tolerability and Pharmacokinetics After Administration of Increasing Dose of BIBN 4096 BS in Healthy Male and Female VolunteersCompletedNCT02194322Phase 1
- Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of 40 mg Telmisartan/5 mg Amlodipine and 80 mg Telmisartan/5 mg Amlodipine in Healthy Male VolunteersCompletedNCT02194309Phase 1
- Relative Bioavailability of Ambroxol Hydrochloride Lozenge in Comparison to Ambroxol Hydrochloride Syrup (Mucosolvan®) in Healthy Female and Male VolunteersCompletedNCT02194296Phase 1
- Study to Evaluate Safety, Tolerability and Pharmacokinetics of Increasing Repeated Oral Doses of Ambroxol Lozenges in Healthy Male VolunteersCompletedNCT02194283Phase 1
- Relative Bioavailability of Ambroxol Hydrochloride of Soft Pastilles Compared to Ambroxol Hydrochloride Syrup in Healthy Male and Female VolunteersCompletedNCT02194270Phase 1
- Investigation of the Metabolism and Pharmacokinetics of Ambroxol in Healthy Male VolunteersCompletedNCT02194257Phase 1
- Pharmacokinetic Properties of Nevirapine Extended Release Tablets When Administered Orally in Healthy Male VolunteersCompletedNCT02194218Phase 1